| abstract |
Compositions of the present anti-APRIL specific antibodies and methods of using such antibodies in the modulation of biologically active APRIL, particularly in the inhibition of inflammatory diseases, cell proliferation and cancer. A binding compound that binds to human APRIL, which is a binding compound that binds to APRIL of the amino acid sequence IRSMPSHPPDRA or VSREGQGRQ. [Selection] Figure 1 |